Biomark Capital is a private equity general partner firm with offices in Russia and United States.
WhiteGlove Health, backed by Enhanced Equity Funds and Biomark Capital, has bought US-based consulting company Glenridge Health Solutions.
Taiwan's JHL Biotech has raised $35m in Series B financing from Milestone Capital, Fubon Financial, TaiAn Technologies and others.
Biomark Capital has spun off from Burrill Capital and will continue to manage the four previous funds' portfolios.
Read more news concerning Biomark Capital
A sampling of Biomark Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?